Vericel
(NASDAQ:VCEL)
$23.85
0.80[3.47%]
At close: Dec 2(Delayed 15-Minutes)
Get Real Time Here
$23.85
After Hours: 4:01PM EDT
Day Range22.21 - 24.2452 Wk Range17.3 - 43.97Open / Close22.82 / 23.85Float / Outstanding34M / 47.2M
Vol / Avg.273.9K / 488.8KMkt Cap1.1BP/E-50d Avg. Price23.71
Div / Yield-Payout Ratio-Total Float34MEPS-0.14

Vericel Stock (NASDAQ:VCEL), Quotes and News Summary

Vericel Stock (NASDAQ: VCEL) stock price, news, charts, stock research, profile.

Loading...
Day Range22.21 - 24.2452 Wk Range17.3 - 43.97Open / Close22.82 / 23.85Float / Outstanding34M / 47.2M
Vol / Avg.273.9K / 488.8KMkt Cap1.1BP/E-50d Avg. Price23.71
Div / Yield-Payout Ratio-Total Float34MEPS-0.14
Globe Newswire - Nov 9, 2022, 7:55AM
Globe Newswire - Aug 3, 2022, 7:55AM
Globe Newswire - May 4, 2022, 7:55AM
TipRanks - Nov 9, 2022, 4:25PM
Seeking Alpha - Nov 9, 2022, 4:01PM
InvestorsObserver - Sep 26, 2022, 3:29PM
InvestorsObserver - Sep 7, 2022, 1:26PM
Seeking Alpha - May 3, 2022, 11:56AM
Seeking Alpha - May 3, 2022, 11:43AM
Seeking Alpha - Apr 17, 2022, 8:49AM
InvestorsObserver - Mar 22, 2022, 3:25PM
InvestorsObserver - Mar 15, 2022, 11:21AM
InvestorsObserver - Feb 23, 2022, 2:30PM
Seeking Alpha - Feb 23, 2022, 1:59PM
Sector: Health Care.Industry: Biotechnology
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-23
REV
Q3 2022Est.ActualSurprise
EPS-0.100-0.140 -0.0400
REV40.990M38.551M-2.439M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Vericel (VCEL) stock?

A

You can purchase shares of Vericel (NASDAQ: VCEL) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Vericel (VCEL) stock?

A

The latest price target for Vericel (NASDAQ: VCEL) was reported by HC Wainwright & Co. on Thursday, November 10, 2022. The analyst firm set a price target for 35.00 expecting VCEL to rise to within 12 months (a possible 46.75% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Vericel (VCEL)?

A

The stock price for Vericel (NASDAQ: VCEL) is $23.85 last updated December 2, 2022, 9:00 PM UTC.

Q

Does Vericel (VCEL) pay a dividend?

A

There are no upcoming dividends for Vericel.

Q

When is Vericel (NASDAQ:VCEL) reporting earnings?

A

Vericel’s Q4 earnings are confirmed for Thursday, February 23, 2023.

Q

Is Vericel (VCEL) going to split?

A

There is no upcoming split for Vericel.

Q

What sector and industry does Vericel (VCEL) operate in?

A

Vericel is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.